ALGN vs. WST, COO, MMSI, HAE, ICUI, XRAY, QDEL, NEOG, STAA, and CERS
Should you be buying Align Technology stock or one of its competitors? The main competitors of Align Technology include West Pharmaceutical Services (WST), Cooper Companies (COO), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.
Align Technology vs. Its Competitors
West Pharmaceutical Services (NYSE:WST) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, media sentiment and institutional ownership.
West Pharmaceutical Services has a net margin of 16.13% compared to Align Technology's net margin of 10.29%. West Pharmaceutical Services' return on equity of 18.23% beat Align Technology's return on equity.
West Pharmaceutical Services has higher earnings, but lower revenue than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.
West Pharmaceutical Services has a beta of 1.09, suggesting that its share price is 9% more volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500.
West Pharmaceutical Services presently has a consensus target price of $320.00, indicating a potential upside of 44.66%. Align Technology has a consensus target price of $241.25, indicating a potential upside of 27.40%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts plainly believe West Pharmaceutical Services is more favorable than Align Technology.
In the previous week, West Pharmaceutical Services had 23 more articles in the media than Align Technology. MarketBeat recorded 39 mentions for West Pharmaceutical Services and 16 mentions for Align Technology. Align Technology's average media sentiment score of 1.49 beat West Pharmaceutical Services' score of 0.37 indicating that Align Technology is being referred to more favorably in the news media.
93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by company insiders. Comparatively, 0.7% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
West Pharmaceutical Services beats Align Technology on 11 of the 16 factors compared between the two stocks.
Get Align Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Align Technology Competitors List
Related Companies and Tools
This page (NASDAQ:ALGN) was last updated on 6/30/2025 by MarketBeat.com Staff
